X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | 2026-10-23 | RAPP | Rapport Therapeutics, Inc. | Pharmaceutical Preparations | 7 | P - Purchase | $21.36 | +1,031,174 | 3,474,390 | +42% | +$22,023,905 | |||||
| 3 | 2026-09-01 | PNFP | Pinnacle Financial Partners, Inc. | National Commercial Banks | 3 | P - Purchase | $98.81 | +13,065 | 440,566 | +3% | +$1,290,941 | |||||
| 6 M | 2026-09-01 | NPB | Northpointe Bancshares Inc | State Commercial Banks | 4 | P - Purchase | $16.23 | +281,552 | 3,428,420 | +9% | +$4,569,382 | |||||
| 4 | 2026-10-28 | TTMI | Ttm Technologies Inc | Printed Circuit Boards | 3 | P - Purchase | $99.50 | +30,000 | 200,473 | +18% | +$2,985,011 | |||||
| 15 M | 2026-10-26 | BPRE | Bluerock Private Real Estate Fund | Closed-End Funds | 3 | P - Purchase | $12.62 | +3,115,121 | 3,128,887 | >999% | +$39,325,588 | |||||
| 2 | 2026-10-26 | ACN | Accenture Plc | Business Services | 2 | P - Purchase | $246.22 | +13,000 | 58,271 | +29% | +$3,200,889 | |||||
| 5 | 2026-10-23 | STC | Stewart Information Services Corp | Title Insurance | 5 | P - Purchase | $46.10 | +10,000 | 272,893 | +4% | +$460,970 | |||||
| 3 M | 2026-08-27 | CTEV | Claritev Corp | Investment Advice | 2 | P - Purchase | $24.34 | +148,118 | 2,484,614 | +6% | +$3,605,876 | |||||
| 2 M | 2026-10-23 | KIO | Kkr Income Opportunities Fund | Closed-End Funds | 2 | P - Purchase | $9.90 | +12,047 | 23,252 | +108% | +$119,288 | |||||
| 2 | 2026-10-23 | THRM | Gentherm Inc | Motor Vehicle Parts & Accessories | 2 | P - Purchase | $26.50 | +25,000 | 205,991 | +14% | +$662,600 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-10-28 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $0.97 | +30,000 | 4,391,946 | +1% | +$29,056 | |||||
2026-10-28 | RAPP | Rapport Therapeutics, Inc. | Healy James | Dir | P - Purchase | $21.00 | +969,480 | 2,873,888 | +51% | +$20,359,080 | ||||||
| M | 2026-10-28 | LYCA | Lycia Therapeutics, Inc. | Venrock Healthcare Capital Partners Iii, L.P. | 10% | P - Purchase | $25.78 | +25,004 | 6,850,237 | 0% | +$644,711 | |||||
2026-10-29 | NBIS | Nebius Group N.V. | Grimme Arne | Dir | P - Purchase | $169.42 | +148 | 7,899 | +2% | +$25,074 | ||||||
2026-10-28 | CRBG | Corebridge Financial, Inc. | Nippon Life Insurance Co | 10% | P - Purchase | $35.26 | +245,898 | 131,869,568 | 0% | +$8,671,495 | ||||||
2026-10-29 | ECF | Ellsworth Growth & Income Fund Ltd | Saba Capital Management, L.P. | 10% | P - Purchase | $11.87 | +5,975 | 1,802,498 | 0% | +$70,923 | ||||||
2026-10-28 | PEO | Adams Natural Resources Fund, Inc. | Nelson Jane Musser | Dir | P - Purchase | $29.93 | +1,010 | 4,135 | +32% | +$30,229 | ||||||
2026-10-28 | BFH | Bread Financial Holdings, Inc. | Fawcett John J. | Dir | P - Purchase | $24.70 | +5,000 | 5,000 | New | +$123,490 | ||||||
2026-10-30 | OCFC | Oceanfirst Financial Corp | Barrett Patrick Sean | Senior EVP, CFO | P - Purchase | $17.90 | +5,000 | 153,560 | +3% | +$89,500 | ||||||
| D | 2026-10-29 | PKBK | Parke Bancorp, Inc. | Pantilione Vito S | Pres, CEO | P - Purchase | $32.86 | +1,300 | 321,094 | 0% | +$42,718 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-10-28 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $0.97 | +30,000 | 4,391,946 | +1% | +$29,056 | |||||
2026-10-27 | BOLD | Boundless Bio, Inc. | Tang Kevin | 10% | P - Purchase | $2.40 | +10,707 | 3,022,456 | 0% | +$25,697 | ||||||
2026-10-28 | ELVR | Elevra Lithium Ltd | Cortes Vargas Christian Mauricio | CFO | P - Purchase | $2.67 | +16,000 | 11,431 | -350% | +$42,720 | ||||||
| D | 2026-10-28 | ACTU | Actuate Therapeutics, Inc. | Schmitt Daniel M | Pres, CEO, Dir | P - Purchase | $0.36 | +140,844 | 1,073,300 | +15% | +$50,000 | |||||
| M | 2026-10-27 | API | Agora, Inc. | Zhao Bin | CEO | P - Purchase | $4.47 | +12,549 | 85,681,849 | 0% | +$56,081 | |||||
2026-10-28 | RCT | Redcloud Holdings Plc | Senn Nikolaus Beat | Dir, 10% | P - Purchase | $0.25 | +1,700,000 | 11,986,524 | +17% | +$425,000 | ||||||
2026-10-26 | XBIT | Xbiotech Inc. | Simard John | Dir, 10% | P - Purchase | $1.93 | +368,524 | 4,191,690 | +10% | +$711,251 | ||||||
| M | 2026-10-23 | NXTC | Nextcure, Inc. | Adar1 Capital Management, LLC | 10% | P - Purchase | $4.95 | +10,851 | 733,270 | +2% | +$53,691 | |||||
| D | 2026-10-20 | DAIO | Data I/O Corp | Red Oak Partners, LLC | 10% | P - Purchase | $2.68 | +373,133 | 373,133 | New | +$999,996 | |||||
| M | 2026-10-23 | API | Agora, Inc. | Zhao Bin | CEO | P - Purchase | $4.44 | +17,598 | 85,669,300 | 0% | +$78,084 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-10-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $425.90 | -3,084 | 46,574 | -6% | -$1,313,470 | |||||
2026-10-30 | GDYN | Grid Dynamics Holdings, Inc. | Livschitz Leonard | CEO | S - Sale | $12.02 | -10,000 | 3,310,394 | 0% | -$120,200 | ||||||
2026-10-30 | GDYN | Grid Dynamics Holdings, Inc. | Doradla Anil | CFO | S - Sale | $10.51 | -20,000 | 374,509 | -5% | -$210,200 | ||||||
2026-10-30 | GDYN | Grid Dynamics Holdings, Inc. | Gryzlov Yury | COO | S - Sale | $10.51 | -10,512 | 484,778 | -2% | -$110,481 | ||||||
| M | 2026-10-28 | UHALB | U-Haul Holding Co /Nv/ | Shoen Mark V | 10% | S - Sale | $49.07 | -46,000 | 86,020,733 | 0% | -$2,257,145 | |||||
| D | 2026-10-29 | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | S - Sale+OE | $14.21 | -8,000 | 239,763 | -3% | -$113,716 | |||||
| M | 2026-10-28 | PACS | Pacs Group, Inc. | Lewis Michelle Renee | Chief Accounting Officer | S - Sale | $50.11 | -11,828 | 343,510 | -3% | -$592,648 | |||||
| D | 2026-10-29 | CAKE | Cheesecake Factory Inc | Clark Matthew Eliot | EVP, CFO | S - Sale+OE | $113.31 | -23,832 | 81,329 | -23% | -$2,700,394 | |||||
| M | 2026-10-28 | PACS | Pacs Group, Inc. | Murray Jason Hulse | Co-Founder, CEO, COB, 10% | S - Sale | $50.09 | -8,803 | 54,179,397 | 0% | -$440,913 | |||||
| M | 2026-10-28 | PACS | Pacs Group, Inc. | Hancock Mark | Dir, 10% | S - Sale | $50.08 | -13,304 | 53,505,580 | 0% | -$666,221 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-10-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $425.90 | -3,084 | 46,574 | -6% | -$1,313,470 | |||||
2026-10-30 | ACAD | Acadia Pharmaceuticals Inc | Schneyer Mark C. | EVP, CFO | S - Sale | $20.88 | -3,321 | 71,322 | -4% | -$69,342 | ||||||
2026-10-30 | GDYN | Grid Dynamics Holdings, Inc. | Livschitz Leonard | CEO | S - Sale | $12.02 | -10,000 | 3,310,394 | 0% | -$120,200 | ||||||
2026-10-30 | GDYN | Grid Dynamics Holdings, Inc. | Doradla Anil | CFO | S - Sale | $10.51 | -20,000 | 374,509 | -5% | -$210,200 | ||||||
2026-10-30 | GDYN | Grid Dynamics Holdings, Inc. | Gryzlov Yury | COO | S - Sale | $10.51 | -10,512 | 484,778 | -2% | -$110,481 | ||||||
2026-10-28 | RAPP | Rapport Therapeutics, Inc. | Healy James | Dir | P - Purchase | $21.00 | +969,480 | 2,873,888 | +51% | +$20,359,080 | ||||||
| M | 2026-10-28 | NEGG | Newegg Commerce, Inc. | Chang Fred Faching | Dir, 10% | S - Sale | $9.85 | -7,164 | 3,698,016 | 0% | -$70,535 | |||||
| M | 2026-10-28 | UHALB | U-Haul Holding Co /Nv/ | Shoen Mark V | 10% | S - Sale | $49.07 | -46,000 | 86,020,733 | 0% | -$2,257,145 | |||||
| M | 2026-10-28 | LYCA | Lycia Therapeutics, Inc. | Venrock Healthcare Capital Partners Iii, L.P. | 10% | P - Purchase | $25.78 | +25,004 | 6,850,237 | 0% | +$644,711 | |||||
| D | 2026-10-29 | SNDX | Syndax Pharmaceuticals Inc | Podlesak Dennis | Dir | M - OptEx | $11.81 | +8,000 | 239,763 | +3% | +$94,480 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |